LII 241220 240.00P (LII241220P240000) Stock Options, News & Quotes

0.00
0.000.00%

15min DelayClose Dec 20 09:30 ET

0.00High0.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo AI

Feb 16 10:45

High levels of insider ownership at Lennox International may suggest the company is run in the interest of all shareholders. However, the selling of shares by insiders over the last year does not inspire confidence.

Lennox International Insiders Sold US$4.9m Of Shares Suggesting Hesitancy

Moomoo AI

Feb 3 07:14

Lennox International's revenue growth is predicted to slow down significantly, with a projected annual growth of 3.3% until 2024, compared to its past five-year growth rate of 6.5%. This is slower than the industry's expected annual growth of 5.0%.

Lennox International Inc. (NYSE:LII) Just Released Its Annual Earnings: Here's What Analysts Think

Moomoo AI

Jan 15 07:38

Lennox International's positive outlook is reflected in its above-industry share price. However, its high PE ratio suggests limited upside from mispricing. Investors should consider other factors, anticipating a potential price drop.

Is Lennox International Inc. (NYSE:LII) Potentially Undervalued?

Moomoo AI

Oct 26, 2023 05:55

CEO Alok Maskara appreciates Reitmeier's strategic leadership that led to substantial shareholder value growth and exceptional financial performance. He also shows confidence in Quenzer who holds a record of success at Lennox.

Press Release: Lennox Announces Chief Financial Officer Leadership Transition Plan

Movers and Shakers

Oct 17, 2023 07:13

Columns Today's Pre-Market Stock Movers and Top Ratings: BAC, WH, JNJ, LMT and More

Pre-Market Stock Movers
Gapping up
$Wyndham Hotels & Resorts (WH.US)$
(The stock soared over 15% after $Choice Hotels International (CHH.US)$ , down 6%, disclosed it made an offer to its rival for about $7.8 billion in a cash and stock deal.)
$Johnson & Johnson (JNJ.US)$
(The stock rose 1.5% after the drugmaker raised its 2023 profit forecast, helped by resilient demand for its anti-inflammatory drug Stelara and recorded a $...